Rouveix B, Larno S, Lechat P
J Pharmacol. 1983 Oct-Dec;14(4):473-84.
Peritoneal exudate cells aggregate when exposed to the lymphokine Macrophage Aggregating Factor (MAgF). The role of prostaglandins in the aggregation of these cells has been investigated with a quantitative assay. Results are discussed in the context of the mode of action of the migration inhibiting factor (MIF) and of the other non immune aggregating stimuli such as C5a and fMLP. Prostaglandins E1, E2, and F2 alpha alone did not cause aggregation of macrophages but partially inhibited the MAgF aggregation of macrophages and this effect was not different from the one obtained with MAgF. MAgF, calcium ionophore A23187 and arachidonic acid induced aggregation were blocked by 5, 8, 11, 14-eicosatetraynoic acid, an inhibitor of arachidonic acid metabolism, by indomethacin (10(-4), 10(-6) M) by corticosteroids (dexamethazone, methylprednisolone, hydrocortisone) but not by aspirin (10(-2), 10(-4) M) nor by phenylbutazone (10(-4), 10(-5) M). These results suggest a causal relationship between MAgF induced macrophage aggregation and that due to other stimuli with respect to the derivatives of arachidonic acid. The lipoxygenase pathways metabolites stimulate aggregation whereas the cyclo-oxygenase pathways metabolites inhibit it.
腹膜渗出细胞在暴露于淋巴因子巨噬细胞聚集因子(MAgF)时会聚集。已通过定量测定法研究了前列腺素在这些细胞聚集中的作用。在迁移抑制因子(MIF)以及其他非免疫聚集刺激物(如C5a和fMLP)的作用模式背景下讨论了结果。单独的前列腺素E1、E2和F2α不会引起巨噬细胞聚集,但会部分抑制巨噬细胞的MAgF聚集,且这种作用与MAgF所产生的作用并无差异。MAgF、钙离子载体A23187和花生四烯酸诱导的聚集被花生四烯酸代谢抑制剂5,8,11,14-二十碳四烯酸、吲哚美辛(10⁻⁴、10⁻⁶ M)、皮质类固醇(地塞米松、甲基泼尼松龙、氢化可的松)所阻断,但不被阿司匹林(10⁻²、10⁻⁴ M)或保泰松(10⁻⁴、10⁻⁵ M)阻断。这些结果表明,MAgF诱导的巨噬细胞聚集与其他刺激物诱导的聚集之间在花生四烯酸衍生物方面存在因果关系。脂氧合酶途径的代谢产物刺激聚集,而环氧化酶途径的代谢产物抑制聚集。